Eticyclidine

Eticyclidine (also known as PCE) is a dissociative anesthetic drug that was developed in the 1960s. It is chemically related to phencyclidine (PCP) and ketamine, and it produces similar effects.

Chemical Structure and Properties

Eticyclidine belongs to the class of arylcyclohexylamine compounds. Its chemical structure consists of a cyclohexane ring bound to an ethylamine group and a phenyl ring. The systematic IUPAC name for eticyclidine is N-ethyl-1-phenylcyclohexan-1-amine.

Pharmacology

Eticyclidine acts primarily as an NMDA receptor antagonist, which inhibits the action of the neurotransmitter glutamate at NMDA receptors in the brain. This inhibition leads to a decrease in neuronal excitability, resulting in the drug's anesthetic and dissociative effects.

Effects

The effects of eticyclidine are similar to those of other dissociative anesthetics like PCP and ketamine. These effects include:

• Dissociation from the environment
• Analgesia
• Hallucinations
• Euphoria
• Altered perception of time and space

Medical Use

Eticyclidine was initially investigated for its potential use as an anesthetic, but due to its potent psychoactive effects and the availability of safer alternatives, it was never widely adopted in clinical practice.

Recreational Use and Legal Status

Eticyclidine has been used recreationally for its hallucinogenic and dissociative effects. However, its use is associated with significant risks, including psychosis, neurotoxicity, and addiction. Due to these risks, eticyclidine is classified as a controlled substance in many countries.

Related Compounds

Eticyclidine is structurally and pharmacologically related to several other compounds, including:

• Phencyclidine (PCP)
• Ketamine
• Methoxetamine (MXE)
• Dizocilpine (MK-801)

See Also

• Dissociative
• NMDA receptor antagonist
• Arylcyclohexylamine